Enjaymo 1100 mg/22 ml, Infusionslösung

7680680740026 CH-68074 Infusionslösung
Enjaymo 1100 mg/22 ml, Infusionslösung
Enjaymo 1100 mg/22 ml, Infusionslösung
Enjaymo 1100 mg/22 ml, Infusionslösung
1 / 3
google

Article details

Package size
6 x 22 ml
Selling units
6
Measure
Durchstechflasche(n)
Galenic form
Infusionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
08/10/2025
Summary of Product Characteristics
Français
08/10/2025
Summary of Product Characteristics
Italien
08/10/2025

Detailed composition

Substance Quantity Type Category
sutimlimabum
50.0 MG Substance Wirkstoff (Principe actif)
natrii dihydrogenophosphas monohydricus
- Substance HNIDK
dinatrii phosphas heptahydricus
- Substance HNIDK
natrii chloridum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
3.45 MG Substance HBESI

Authorization holder

RECORDATI AG

4057 Basel

Authorization information

Swissmedic authorization number
68074
Drug name
Enjaymo, Infusionslösung
Galenic form
LSINF
ATC Code
L04AJ04
Authorization status
Z
Dispensing category
A
First authorization
21/06/2023
Authorization expiration date
20/06/2028
IT Number
07.15.0.
Domain
Human medicine
Field of application
Behandlung der Hämolyse bei erwachsenen Patienten mit Kälteagglutininkrankheit

Package details

Description (FR)
ENJAYMO sol perf 1100 mg/22ml 6 flac 22 ml
Description (DE)
ENJAYMO Inf Lös 1100 mg/22ml 6 Durchstf 22 ml
Market launch
21/06/2023
Narcotic (BTM)
No

Other package sizes (1)

ENJAYMO sol perf 1100 mg/22ml flac 22 ml
1 x 22 ml DUR
GTIN: 7680680740019
View
Buy us a coffee Explore the data